Channel Therapeutics Corporation (CHRO)
Jul 2, 2025 - CHRO was delisted (reason: merged into PTHS)
13.50
0.00 (0.00%)
Inactive · Last trade price on Jul 1, 2025

Channel Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Channel Therapeutics.

Price Target: n/a
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

There are currently no analyst ratings available for Channel Therapeutics.

Recommendation Trends

RatingJun '24
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
Total0

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Alliance Global Partners
Alliance Global Partners
Strong Buy
Initiates
n/a
Strong BuyInitiatesn/an/aJun 18, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.12
from -1.43
EPS Next Year
-1.12
from -1.12
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2025Dec 31, 2026
Revenue
199.93K-------
Revenue Growth
--------
EPS
---5.65-5.78-1.43-1.12-1.12-1.07
EPS Growth
--------
Forward PE
--------
No. Analysts
-----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.